Multiplex Assay Kit for Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD220; ISR; HHF5; IR

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 89-96 92
EDTA plasma(n=5) 90-97 94
heparin plasma(n=5) 96-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-101% 93-101% 88-101% 92-101%
EDTA plasma(n=5) 87-98% 86-93% 90-98% 83-104%
heparin plasma(n=5) 87-96% 78-92% 89-97% 98-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:INSR) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
IOSR Journal of Applied Chemistry Molecular and Biochemical Effect of Neem Extract On Experimental Diabetes Org:Source
Biol Pharm Bull Age-Dependent Onset of Insulin Resistance in Insulin-Resistant Mice PubMed: 26632184
Nanomedicine A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes pubmed:27623396
American Journal of Translational Research Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β. pubmed:28337257
Biomedicine & Pharmacotherapy Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylationin diabetic rats. pubmed:27930980
Eur Neuropsychopharmacol. Regulation of insulin receptor phosphorylation in the brains of prenatally stressed rats: New insight into the benefits of antidepressant drug treatment. pubmed:28063625
台湾农业研究 (台灣農業研究67 (4): 355-364) 香菇柄水萃物改善糖尿病降低阿茲海默氏症罹病風險初探
Scientific Reports Mechanism underlying starvation-dependent modulation of olfactory behavior in Drosophila larva Pubmed: 32080342
ADVANCED RESEARCHES Prenatal Stress Induced Spatial Memory Deficit in a Sex-Specific Manner in Mice: Possible Involvement of Hippocampal Insulin Resistance
Current Biology Internal State Affects Local Neuron Function in an Early Sensory Processing Center to Shape Olfactory Behavior in Drosophila Larvae
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPA895Ra01 Recombinant Insulin Receptor (INSR) Positive Control; Immunogen; SDS-PAGE; WB.
PAA895Ra01 Polyclonal Antibody to Insulin Receptor (INSR) WB; IHC; ICC; IP.
MAA895Ra22 Monoclonal Antibody to Insulin Receptor (INSR) WB; IHC; ICC; IP.
MAA895Ra23 Monoclonal Antibody to Insulin Receptor (INSR) WB; IHC; ICC; IP.
MAA895Ra21 Monoclonal Antibody to Insulin Receptor (INSR) WB; IHC; ICC; IP.
SEA895Ra ELISA Kit for Insulin Receptor (INSR) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA895Ra Multiplex Assay Kit for Insulin Receptor (INSR) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.